Literature DB >> 14996307

Cost of renal replacement therapy in Turkey.

Ekrem Erek1, MehmetT Sukru Sever, Emel Akoglu, Muzaffer Sariyar, Semra Bozfakioglu, Suheyla Apaydin, Rezzan Ataman, Nedim Sarsmaz, Mehmet Riza Altiparmak, Nurhan Seyahi, Kamil Serdengecti.   

Abstract

BACKGROUND AND
RESULTS: By the end 2000, 22224 patients were on renal replacement therapy (RRT) in Turkey. We investigated the cost of RRT in three medical faculties and one private dialysis centre. Yearly expenses were US dollars 22759 for haemodialysis (HD), US dollars 22350 for continuous ambulatory peritoneal dialysis (CAPD), and US dollars 23393 and US dollars 10028, respectively, for the first and second years of transplantation (Tx). In the first year, renal Tx was significantly more expensive than CAPD. However, after the first year of renal transplantation, Tx became significantly more economical than both CAPD and HD. The sum of all yearly RRT expenses for the country was US dollars 488958709, which corresponds to nearly 5.5% of Turkey's total health expenditure.
CONCLUSION: Measures such as early construction of vascular access, promoting home dialysis and the reuse of the dialysers, strict control of the use of some expensive drugs like erythropoietin and active vitamin D, and also increasing the number of transplantations, especially if pre-emptive transplantation is possible, should be taken into account in order to reduce these expenses.

Entities:  

Mesh:

Year:  2004        PMID: 14996307     DOI: 10.1111/j.1440-1797.2003.00218.x

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  4 in total

1.  Direct medical costs of end-stage kidney disease and renal replacement therapy: a cohort study in Guangzhou City, southern China.

Authors:  Hui Zhang; Chao Zhang; Sufen Zhu; Hongjian Ye; Donglan Zhang
Journal:  BMC Health Serv Res       Date:  2020-02-14       Impact factor: 2.655

2.  Report of the first peritoneal dialysis program in Guyana, South America.

Authors:  Maria Altieri; Tarun R Jindal; Mayur Patel; David K Oliver; Edward M Falta; Eric A Elster; Alden Doyle; Stephen R Guy; Arthur L Womble; Rahul M Jindal
Journal:  Perit Dial Int       Date:  2013 Mar-Apr       Impact factor: 1.756

3.  Three years evaluation of peritoneal dialysis and hemodialysis absorption costing: perspective of the service provider compared to funds transfers from the public and private healthcare systems.

Authors:  Alyne Schreider; Celso Souza de Moraes Júnior; Natália Maria da Silva Fernandes
Journal:  J Bras Nefrol       Date:  2022 Apr-Jun

Review 4.  The cost of dialysis in low and middle-income countries: a systematic review.

Authors:  Lawrencia Mushi; Paul Marschall; Steffen Fleßa
Journal:  BMC Health Serv Res       Date:  2015-11-12       Impact factor: 2.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.